Open tender · Czechia · Antineoplastic agents
Léčivé přípravky s obsahem účinné látky apalutamid 2026
In EnglishMedicinal products containing the active substance apalutamide 2026
Fakultní nemocnice Plzeň in Czechia is inviting bids for “Medicinal products containing the active substance apalutamide 2026”. Bids close on 14 October 2026, 09:00 CEST; the estimated value is CZK 247 million. askTender lists every requirement to qualify and checks whether your company meets them.
The tender in brief
A three-year supply of apalutamide prostate cancer medicines to a Czech hospital, for licensed pharmaceutical suppliers
Fakultní nemocnice Plzeň is buying apalutamide medicines for hormone-sensitive prostate cancer treatment at its workplaces. The expected total volume is 360 000 individual doses, supplied over three years from signing the purchase contract. Two oral forms are required: 60 mg and 240 mg apalutamide.
Key facts
- Estimated value
- CZK 247 million
- Procedure
- Contract notice
- Contract period
- Three years from signing the purchase contract
- How bids are judged
- Lowest bid price for the total expected annual volume in CZK including VAT
Before you bid, askTender
Everything else is in your askTender account
The requirements to qualify, the eligibility check and the bid documents for this tender are in your askTender account.
- What it takes to qualify: every requirement, in the tender’s own words
- Whether your company qualifies: your profile checked against each requirement, showing what you have, what’s missing and how to close the gap
- The documents to file: a checklist, with draft declarations ready to sign
- A bid partner for any requirement you can’t meet alone
- The tender documents, ready to open
- Alerts for new tenders like this one
Public data: TED – Tenders Electronic Daily. © European Union, 1998–2026. Notices reused under Commission Decision 2011/833/EU. · Sources & licences